Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-06-09 5:30 pm Purchase | 2026-06-05 | 13D | JADE BIOSCIENCES, INC. JBIO | Fairmount Funds Management LLC | 14,069,494 19.990% | 3,715,619![]() (+35.89%) | Filing History |
| 2026-05-15 4:31 pm Sale | 2026-03-31 | 13G | ENLIVEN THERAPEUTICS INC ELVN | Fairmount Funds Management LLC | 1,855,644 3.100% | -1,855,800![]() (-50.00%) | Filing History |
| 2026-05-13 4:30 pm Purchase | 2026-05-11 | 13D | VIRIDIAN THERAPEUTICS INC VRDN | Fairmount Funds Management LLC | 17,201,800 14.040% | 1,176,470![]() (+7.34%) | Filing History |
| 2026-05-04 6:00 pm Purchase | 2026-04-30 | 13D | ORUKA THERAPEUTICS INC ORKA | Fairmount Funds Management LLC | 13,665,080 19.990% | 2,502,339![]() (+22.42%) | Filing History |
| 2026-04-20 6:00 pm Purchase | 2026-04-16 | 13D | SPYRE THERAPEUTICS, INC SYRE | Fairmount Funds Management LLC | 9,016,702 9.990% | 909,820![]() (+11.22%) | Filing History |
| 2026-03-31 9:30 pm Sale | 2026-03-31 | 13D | COGENT BIOSCIENCES INC COGT | Fairmount Funds Management LLC | 15,356,918 8.600% | -905,000![]() (-5.57%) | Filing History |
| 2026-03-27 5:30 pm Purchase | 2026-03-26 | 13D | APOGEE THERAPEUTICS INC APGE | Fairmount Funds Management LLC | 6,764,974 9.990% | 717,947![]() (+11.87%) | Filing History |
| 2026-02-17 4:30 pm Purchase | 2025-12-31 | 13G | INHIBIKASE THERAPEUTICS INC CO IKT | Fairmount Funds Management LLC | 12,461,101 9.900% | 5,442,526![]() (+77.54%) | Filing History |
| 2026-02-11 6:11 pm Purchase | 2026-02-09 | 13D | DAMORA THERAPEUTICS, INC DMRA | Fairmount Funds Management LLC | 8,713,000 19.990% | 8,316,000![]() (+2094.71%) | Filing History |
| 2026-01-22 8:02 pm Purchase | 2026-01-22 | 13D | COGENT BIOSCIENCES INC COGT | Fairmount Funds Management LLC | 16,261,918 9.900% | 384,500![]() (+2.42%) | Filing History |
| 2026-01-22 8:00 pm Purchase | 2026-01-22 | 13D | APOGEE THERAPEUTICS INC APGE | Fairmount Funds Management LLC | 6,047,027 9.990% | 270,146![]() (+4.68%) | Filing History |
| 2025-12-08 4:30 pm Purchase | 2025-12-04 | 13D | CRESCENT BIOPHARMA, INC CBIO | Fairmount Funds Management LLC | 5,643,482 18.530% | 2,519,262![]() (+80.64%) | Filing History |
| 2025-11-25 9:00 pm Sale | 2025-11-21 | 13D | DIANTHUS THERAPEUTICS INC DNTH | Fairmount Funds Management LLC | 2,139,635 4.900% | -1,912,417![]() (-47.20%) | Filing History |
| 2025-11-17 9:45 pm Purchase | 2025-11-10 | 13D | DAMORA THERAPEUTICS, INC DMRA | Fairmount Funds Management LLC | 397,000 19.990% | 397,000![]() (New Position) | Filing History |
| 2025-11-17 4:36 pm Purchase | 2025-11-13 | 13D | COGENT BIOSCIENCES INC COGT | Fairmount Funds Management LLC | 15,877,418 9.900% | 1,552,500![]() (+10.84%) | Filing History |
| 2025-10-27 4:31 pm Purchase | 2025-10-23 | 13D | VIRIDIAN THERAPEUTICS INC VRDN | Fairmount Funds Management LLC | 16,025,330 15.140% | 468,645![]() (+3.01%) | Filing History |
| 2025-10-17 5:00 pm Purchase | 2025-10-15 | 13D | SPYRE THERAPEUTICS, INC SYRE | Fairmount Funds Management LLC | 8,106,882 9.990% | 3,598,303![]() (+79.81%) | Filing History |
| 2025-10-15 09:27 am Sale | 2025-10-14 | 13G | ASTRIA THERAPEUTICS INC ATXS | Fairmount Funds Management LLC | 2,377,049 4.000% | -3,491,988![]() (-59.50%) | Filing History |
| 2025-10-14 7:11 pm Purchase | 2025-10-10 | 13D | APOGEE THERAPEUTICS INC APGE | Fairmount Funds Management LLC | 5,776,881 9.990% | 1,014,323![]() (+21.30%) | Filing History |
| 2025-10-08 4:15 pm Purchase | 2025-10-06 | 13D | JADE BIOSCIENCES, INC. JBIO | Fairmount Funds Management LLC | 10,353,875 19.990% | 3,104,519![]() (+42.82%) | Filing History |

